Lemoine, Maud <br/><br/>
Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.  [electronic resource] 

 -  The Lancet. Global health  08 2016 
 - e559-67 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2214-109X 
<br/><br/><label>Standard No.: </label>10.1016/S2214-109X(16)30130-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Antiviral Agents<br/>Blood Donors<br/>Communicable Diseases<br/>Feasibility Studies<br/>Female<br/>Gambia--epidemiology<br/>Hepatitis B--diagnosis<br/>Hepatitis B Surface Antigens--blood<br/>Hepatitis B virus--immunology<br/>Humans<br/>Liver Cirrhosis--diagnosis<br/>Male<br/>Mass Screening--methods<br/>Middle Aged<br/>Point-of-Care Systems<br/>Prevalence<br/>Sex Factors